Recent news & events:
-
799-P: Gender Differences in Diabetes Distress Comparing Dapagliflozin plus Saxagliptin to Glimepiride When Added to Metformin in Poorly Controlled Type 2 Diabetes
810-P: Patient-reported outcomes in T2D patients inadequately controlled by metformin are more favorable for dapagliflozin plus saxagliptin vs. insulin glargine.
1520-P: Impact of Patient-Centered Factors on Comparative Effectiveness of Initial Therapies in Treatment-Naïve T2D
search:
Follow our blog:
Enter your email address to follow this blog and receive notifications of new posts by email.Annual Research Meeting of AcademyHealth, June 26 – 28, 2016
Annual Research Meeting of AcademyHealth, June 26 – 28, 2016 Oral Presentation: Effect of Medication Reconciliation on Emergency Department.1387-P — 2016 ePoster Electronic Documentation of Lifestyle Counseling in Primary Care Is Associated with Lower Risk of Cardiovascular Events in Patients with Diabetes Health Care Delivery/Economics- Presented Sunday – Jun 12, 2016 12:00 PM – 2:00 PM
HUABING ZHANG,NAOSHI HOSOMURA, MARIA SHUBINA, DONALD C. SIMONSON, MARCIA A. TESTA, ALEXANDER TURCHIN Electronic Documentation of Lifestyle Counseling in.1216-P — 2016 ePoster Effect of Medication Reconciliation on Emergency Department Visits and Hospitalizations in Patients with Diabetes Health Care Delivery/Economics- Presented Sunday – Jun 12, 2016 12:00 PM – 2:00 PM
OLUKAYODE SOSINA, HUABING ZHANG, MARIA SHUBINA,SONALI P. DESAI, DONALD C. SIMONSON, MARCIA A. TESTA Effect of Medication Reconciliation on.1235-P — 2016 ePoster Patient-Centered Outcomes and Socio-Demographic Predictors of Diabetes Treatment Effectiveness Health Care Delivery Economics – Presented Sunday – Jun 12, 2016 12:00 PM – 2:00 PM
MARCIA A. TESTA, MAXWELL SU, ALEXANDER TURCHIN, DONALD C. SIMONSON, Boston, MA Patient-Centered Outcomes and Socio-Demographic Predictors of Diabetes Treatment.823-P — 2016 ePoster: Impact of Subclinical Depression and Anxiety on Intensity and Frequency of Treatment-Related Side Effects and Symptoms Psychosocial, Behavioral Medicine – Presented Saturday – Jun 11, 2016 11:30 AM – 1:30 PM
MARCIA A. TESTA, LINDA G. MARC, ALEXANDER TURCHIN, DONALD C. SIMONSON, Boston, MA Impact of Subclinical Depression and Anxiety.770-P — 2015 ePoster: Health Education Internet Use by Persons with Diabetes in the U.S.
DONALD C. SIMONSON, LINDA G. MARC, MARCIA A. TESTA, Boston, MA Diabetes Education Presented on Monday, June 8, 2015.Recent news & events:
-
799-P: Gender Differences in Diabetes Distress Comparing Dapagliflozin plus Saxagliptin to Glimepiride When Added to Metformin in Poorly Controlled Type 2 Diabetes
810-P: Patient-reported outcomes in T2D patients inadequately controlled by metformin are more favorable for dapagliflozin plus saxagliptin vs. insulin glargine.
1520-P: Impact of Patient-Centered Factors on Comparative Effectiveness of Initial Therapies in Treatment-Naïve T2D
search:
Follow our blog:
Enter your email address to follow this blog and receive notifications of new posts by email.
In 1987, Phase V Technologies, Inc. was founded by the University of Connecticut Research and Development Corporation and named to signify its mission to extend drug development beyond Phase 1 through Phase 4 endpoints and data collection methods. The term “Phase V®” was trademarked as the “fifth phase” of drug development to signify technological advancements in the collection of direct-from-patient assessments and patient-centered outcomes.
Infomation
- Call us: 1-781-237-7737
- Address: 20 Walnut Street, Suite 110, Wellesley Hills, MA 02481
- Need Help: phasev@phasevtechnologiesinc.com
- work time: Mon - Fri : 9.00 am - 5.00 pm
Newsletter
Keep up to date with news from UNSNEC Business. A once a week email with no spam.Recent Posts
Copyright © UNSNEC 2019. All Right Reserved